| Description |
| Product Type |
Product Size |
| Injection |
5'S |
| Product Company |
| Novartis Pharma |
Ondansetron 8mg/4ml
|
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Aqvida |
|
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Pfizer
|
Carboplatin 150mg/15ml
|
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Himmel Pharma |
|
| Product Type |
Product Size |
| Tablet |
30'S |
| Product Company |
| Sanofi |
Furosemide and amiloride 5mg |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Pfizer
|
Cisplatin 50mg
|
| Content | Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery.
| Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin. It is typically administered in combination with fluorouracil and leucovorin in a combination known as Folfox for the treatment of colorectal cancer. Compared to cisplatin the two amine groups are replaced by cyclohexyldiamine for improved antitumour activity. The chlorine ligands are replaced by the oxalato bidentate derived from oxalic acid in order to improve water solubility. | Carboplatin is a platinum-containing chemotherapy medicine, which belongs to the alkylating agents group of medicines. It is used to treat various cancers. It prevents growth of cancerous cells by damaging their DNA that aids in its proliferation.
| Docetaxel is a taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. | A combination of Furosemide and Amiloride is a diuretic which reduces the potassium loss of furosemide alone while avoiding the possible gastro-intestinal disturbances of potassium supplements.
| Cisplatin is a platinum based chemotherapy agent used to treat various sarcomas, carcinomas, lymphomas, and germ cell tumors. |
Reviews
There are no reviews yet.